Philip Morris International Inc (PM) — closed signal from April 28, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on July 27, 2026.
Predicted vs. what happened
PM price · publication thesis → realized outcomesplit-adjusted
$157.38 – $162.30Entry zone — fair-value band
$163.06Published — price the day we called it
$181.12Target — the price the thesis aimed for
$199.78Peak — highest point inside the window, not a realized return
$195.66Window close — end-of-window price, context only
What happened
Target reached
Reached its target in 14 days.
Peak price
$199.78
peak on July 22, 2026 — not a realized returnPeak gain
+22.5%
peak, from the publication priceWindow close
$195.66
end-of-window price, context onlyDays to target
14
Window
April 28, 2026 – July 27, 2026
The thesis — published April 28, 2026
Predicted growth
+12%
over the measurement windowTarget price
$181.12
the price the thesis aimed forEntry zone
$157.38 – $162.30
the fair-value band we waited forPrice at publication
$163.06
published April 28, 2026Confidence
69%
how strongly the data lined upTimeframe
Short-term (0–3 months)
Philip Morris looks clearer than many consumer staples because growth is coming from smoke-free products and the ZYN oral nicotine brand, while quarterly results were solid. Insider stock sales and the companys debt level reduce confidence, and the stock is not deeply cheap. Near-term setup seems constructive but less exciting than stronger cyclical names.
Primary drivers
- Smoke-free products are shifting sales toward higher-growth items
- ZYN oral nicotine is large enough to move overall sales
- A recent earnings beat shows the business is executing
- Insider selling and higher debt lower conviction
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Lyra
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.